Metastatic Basal cell carcinoma
Also known as: Metastatic basal cell carcinoma (BCC) / Metastatic basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma metastatic / Metastatic basal cell carcinoma (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB14707 | Cemiplimab | A programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. |
DB08828 | Vismodegib | A hedgehog pathway inhibitor used to treat patients with locally advanced or metastatic basal cell carcinoma. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB14681 | Cortisone | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB00959 | Methylprednisolone | 1 | Active Not Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB00635 | Prednisone | 1 | Active Not Recruiting | 1 |
DB00864 | Tacrolimus | 1 | Active Not Recruiting | 1 |
DB14681 | Cortisone | 1 / 2 | Recruiting | 1 |
DB06186 | Ipilimumab | 1 / 2 | Recruiting | 1 |
DB00959 | Methylprednisolone | 1 / 2 | Recruiting | 1 |
DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
DB00635 | Prednisone | 1 / 2 | Recruiting | 1 |
DB00877 | Sirolimus | 1 / 2 | Recruiting | 1 |
DB08828 | Vismodegib | 4 | Completed | 1 |
DB09143 | Sonidegib | Not Available | Recruiting | 1 |
DB08828 | Vismodegib | Not Available | Recruiting | 1 |